Matrix Pharmacorp is an API manufacturer based in India. It holds 223 active US drug master files. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 28 November 2025 as VAI. Customs aggregates show $7.4M of exports covering 51 molecules to 16 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Vizianagaram, India | 3002785310 |
| Visakhapatnam, India | 3008861594 |
| Hyderabad, India | 3003227156 |
| Visakhapatnam, India | 3009590042 |
| Hyderabad, India | 3004713397 |
| Molecule | Regulators | Docs |
|---|---|---|
| Darunavir | US FDA | 3 |
| Efavirenz | US FDA | 3 |
| Emtricitabine | US FDA | 3 |
| Esomeprazole | US FDA | 3 |
| Paliperidone | US FDA | 3 |
| Tenofovir Disoproxil | US FDA | 3 |
| Alprazolam | US FDA | 2 |
| Aripiprazole | US FDA | 2 |
| Atazanavir | US FDA | 2 |
| Cabotegravir | US FDA | 2 |
| Canagliflozin | US FDA | 2 |
| Carvedilol | US FDA | 2 |
| Dolutegravir | US FDA | 2 |
| Eletriptan | US FDA | 2 |
| Elvitegravir | US FDA | 2 |
| Epinephrine | US FDA | 2 |
| Felbamate | US FDA | 2 |
| Iron Sucrose | US FDA | 2 |
| Lamivudine | US FDA | 2 |
| Lanthanum Carbonate | US FDA | 2 |
| Mafenide | US FDA | 2 |
| Nepafenac | US FDA | 2 |
| Phentolamine | US FDA | 2 |
| Pomalidomide | US FDA | 2 |
| Raltegravir | US FDA | 2 |
| Sertraline | US FDA | 2 |
| Stavudine | US FDA | 2 |
| Sugammadex | US FDA | 2 |
| Tetrabenazine | US FDA | 2 |
| Valganciclovir | US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 3 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $14.0M | 29 |
| 2025 | Not reported | $7.4M | 16 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Matrix Pharmacorp comes back tiered against every other supplier able to file there.
Start for free